isoborneol has been researched along with tanshinone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, LJ; Li, JP; Liu, SL; Shi, LY; Wang, H; Xie, BP; Zhang, J | 1 |
| Cai, X; Huang, Y; Peng, X; Song, Q; Wang, B; Wang, C; Xiong, X; Ye, X; Zeng, T; Zhang, C | 1 |
| Du, J; Feng, J; Hu, K; Liu, M; Wang, L; Xu, L; Zhao, X | 1 |
3 other study(ies) available for isoborneol and tanshinone
| Article | Year |
|---|---|
The effects of borneol on the pharmacokinetics and brain distribution of tanshinone IIA, salvianolic acid B and ginsenoside Rg
Topics: Abietanes; Animals; Benzofurans; Brain; Camphanes; Chromatography, Liquid; Drugs, Chinese Herbal; Ginsenosides; Male; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2021 |
Borneol-modified tanshinone IIA liposome improves cerebral ischemia reperfusion injury by suppressing NF-κB and ICAM-1 expression.
Topics: Abietanes; Animals; Brain Ischemia; Camphanes; Intercellular Adhesion Molecule-1; Liposomes; NF-kappa B; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2021 |
Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury.
Topics: Abietanes; Adjuvants, Pharmaceutic; Administration, Intranasal; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Brain Ischemia; Camphanes; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Malondialdehyde; Nanoparticles; Neuroprotective Agents; Particle Size; Polyethylene Glycols; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Reperfusion Injury; Succinimides; Superoxide Dismutase | 2021 |